Press Release

Aug, 21 2024

Increasing Demand for Skin Grafts in Burn Treatments Driving the Growth of the Asia-Pacific Deep Partial-thickness Thermal Burns Treatment Market

The increasing demand for skin grafts in burn treatments are significantly driving the Asia Pacific deep partial-thickness thermal burns treatment market. Due to these rising burn cases around Asia-Pacific, there is emergent need for better and advanced treatment options. Most commonly considered treatment being skin graft usage, is also increased due to growth in demand of burn care treatments. Research and development has enhanced customization in grafting and dressing products since cells and tissues of all human are not same. Common researches taken over the area includes research into stem cells, grafting, biomarkers and inflammation control in order to improve individualized care and create new treatment options for these patients. The benefits associated with the minimally invasive are enormous in any medical application and the most important one being the burn care treatments.

Access Full Report @ https://www.databridgemarketresearch.com/jp/reports/asia-pacific-deep-partial-thickness-thermal-burns-treatment-market

Data Bridge Market Research analyzes that the Asia-Pacific Deep Partial-Thickness Thermal Burns Treatment Market is expected to reach USD 683.41 million by 2031 from USD 328.24 million in 2023, growing at a CAGR of 10.1% in the forecast period of 2024 to 2031.

Key Findings of the Study

Asia-Pacific Deep Partial-thickness Thermal Burns Treatment Market

Increasing Demand for Minimally Invasive Procedures

Minimally invasive procedures involves the surgical procedure performed with minute incisions on the body or skin. Various minimally invasive procedures like eschar removal-debridement techniques are lately carried out for numerous burns treatments. The supremacy of minimally invasive procedures includes short recovery time, low risk of infection, less bleeding, small scars, and shorter hospital stays. Burns are very common but sometimes devastating injuries are resulted which leads to morbidity and mortality. The presence of a denaturized protein necrotic eschar which forms over the injured skin layer characterizes the severity of the burn by progressing an inflammatory reaction, delaying in the process of healing and increasing the risks of infection and subsequent scarring over the skin.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016–2021)

Quantitative Units

Revenue in USD Million

Segments Covered

Burn Type (Fire Burn Injuries, Scald Burn, and Hot Objects), Treatment (Initial Wound Care, Physical and Occupational Therapy, and Others), Route of Administration (Topical, Oral, and Others), By Population (Pediatric, Geriatric, and Adult), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Home Healthcare), Distribution Channel (Direct Tender, Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy)

Countries Covered

China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Malaysia, Philippines, and Rest of Asia-Pacific

Market Players Covered

B. Braun SE (Germany), Integra LifeSciences (U.S.), Pfizer Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), AVITA Medical Inc. (U.S.), ConvaTec Inc. (U.K.), 3M (U.S.), Medline Industries, Inc. (U.S.), Smith & Nephew (U.S.), Mediwound (U.S.), and among others.

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Segment Analysis

The Asia-Pacific deep partial-thickness thermal burns treatment market is segmented into six notable segments based on burn type, treatment, route of administration, population, end user, and distribution channel.

  • Based on burn type, the Asia-Pacific deep partial-thickness thermal burns treatment market is segmented into fire burn injuries, scald burn, and hot objects

In 2024, fire burn injuries segment is expected to dominate the Asia-Pacific deep partial-thickness thermal burns treatment market

In 2024, fire burn injuries segment is expected to dominate the Asia-Pacific deep partial-thickness thermal burns treatment market with 51.65% market share due to the incidence rate of fire burn have increased in recent years regionally.

  • Based on treatment, the Asia-Pacific deep partial-thickness thermal burns treatment market is segmented into initial wound care, physical and occupational therapy, and others

In 2024, initial wound care segment is expected to dominate the Asia-Pacific deep partial-thickness thermal burns treatment market

In 2024, initial wound care segment is expected to dominate the Asia-Pacific deep partial-thickness thermal burns treatment market with 65.13% market share due to it’s required in every type of burn and have less side effects and infections.

  • Based on route of administration, the Asia-Pacific deep partial-thickness thermal burns treatment market is segmented into topical, oral and others. In 2024, topical segment is expected to dominate the Asia-Pacific deep partial-thickness thermal burns treatment market with 52.66% market share
  • Based on population, the Asia-Pacific deep partial-thickness thermal burns treatment market is segmented into pediatric, geriatric and adult. In 2024, pediatric segment is expected to dominate the Asia-Pacific deep partial-thickness thermal burns treatment market with 60.72% market share
  • Based on end user, the Asia-Pacific deep partial-thickness thermal burns treatment market is segmented into hospitals, specialty clinics, ambulatory surgical centers, home healthcare and others. In 2024, hospital segment is expected to dominate the Asia-Pacific deep partial-thickness thermal burns treatment market with 49.74% market share
  • Based on distribution channel, the Asia-Pacific deep partial-thickness thermal burns treatment market is segmented into direct tender, hospital pharmacy, online pharmacy, retail pharmacy and others. In 2024, direct tender segment is expected to dominate the Asia-Pacific deep partial-thickness thermal burns treatment market with 34.67% market share

Major Players

Data Bridge Market Research analyzes B. Braun SE (Germany), Pfizer Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Medline Industries, Inc. (U.S.), Smith & Nephew (U.S.) as the major players operating in the market.

Asia-Pacific Deep Partial-thickness Thermal Burns Treatment Market

Market Development

  • In March 2021, Medline industries, Inc announced that they have been awarded a prime vendor contract to serve as the exclusive supply vendor for Windsor Lane Health Care, an Ohio-based long-term care facility which have increases their supply chain
  • In January 2020, Medline Industries, Inc. announced the acquisition of Médi-Sélect, a Quebec City-based medical and dental supplies distributor to join its Medline Canada operations which have increased their distribution and supply chain network
  • In March 2021, B. Braun Melsungen AG has announced that they have reconstituted their Supervisory Board with four new shareholders for their company. They resumed their work on the inaugural day session thereby enhancing company’s product production and product portfolio. This is expected to increase their revenue for the future market
  • In April 2024, Smith+Nephew’s PICO Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE). As a result, NICE has reconfirmed its guidance that PICO sNPWT should be considered as an option for closed surgical incisions in patients who are at high risk of surgical site infections, remains the same. Key high-risk factors include a high body mass index (BMI), diabetes, renal insufficiency and smoking among others.
  • In December 2023, Pfizer Inc. got FDA approval for PADCEV (enfortumab vedotin-eify) in combination with KEYTRUDA (pembrolizumab) as the initial and exclusive ADC Plus PD-1 treatment for advanced bladder cancer. This helped the company to stay in the competition

Regional Analysis

Geographically, the countries covered in the Asia-Pacific deep partial-thickness thermal burns treatment market report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Malaysia, Philippines, and rest of Asia-Pacific.

As per Data Bridge Market Research analysis:

China is the dominant and fastest growing country in the Asia-Pacific deep partial-thickness thermal burns treatment market

China is expected to be the dominant and fastest growing country in the market due to the increasing demand for skin grafts in burn treatments.

For more detailed information about the Asia-Pacific deep partial-thickness thermal burns treatment market report, click here – https://www.databridgemarketresearch.com/jp/reports/asia-pacific-deep-partial-thickness-thermal-burns-treatment-market


Client Testimonials